Indicated for: glaucoma; ocular hypertension
Route of administration: ophthalmic
Substance: brimonidine (glaucoma agent)
ATC: S01EA05 (Sensory organs | Antiglaucoma preparations and miotics | Sympathomimetics in glaucoma therapy)
Brimonidine is a medication used to treat open-angle glaucoma and ocular hypertension. It belongs to the class of alpha-2 adrenergic receptor agonists and works by reducing the production of aqueous humor and increasing its outflow, thereby lowering intraocular pressure.
It is available as eye drops and is typically administered two to three times a day, as directed by a doctor. Brimonidine is effective in preventing optic nerve damage caused by elevated intraocular pressure.
Side effects may include a burning or stinging sensation in the eyes, dry eyes, redness, headache, drowsiness, or dizziness. It is contraindicated in patients taking monoamine oxidase inhibitors (MAOIs) and should be used with caution in those with severe cardiovascular conditions.